IP Library › Granted Patent US 10,000,770
Granted Patent B2
US 10,000,770 · App. 14/963,163 · Granted Jun 19, 2018

Methods of expressing products in mammalian cells

Inventors: Imandokht Famili (San Diego, CA); Renata Usaite Black (San Diego, CA); Christophe H. Schilling (San Diego, CA)
Assignee: INTREXON CEU, INC.
C12N15/85C12N9/0071C12Y114/16001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,000,770
App. No.
14/963,163
Granted
Jun 19, 2018
Kind
B2
Abstract

The invention relates to newly identified selectable marker systems, cells for use in a selectable marker system, and methods for using the selectable marker systems.

Claims (25)

1. A method of expressing a product in a mammalian cell, the method comprising:

(a) contacting mammalian cells lacking expression of a protein with (i) an exogenous mammalian nucleic acid comprising a nucleic acid encoding said protein and with (ii) an expressible nucleic acid encoding said product, wherein said contacting results in uptake of said exogenous mammalian nucleic acid into at least one of said cells,

wherein the protein is selected from the group consisting of: argininosuccinate lyase, cystathionine G-lyase, cystathionine b-synthase, glycine N-methyltransferase, pyrroline-5-carboxylate synthetase, phenylalanine 4-monooxygenase, carbamoyl-phosphate synthase (ammonia), ornithine carbamoyltransferase (mitochondrial), ornithine transaminase (mitochondrial), methionine adenosyltransferase, adenosylhomocysteinase, propionyl-CoA carboxylase (mitochondrial), methylmalonyl-CoA epimerase (mitochondrial), methylmalonyl-CoA mutase, myo-Inositol-1-phosphate synthase, thymidylate synthase, nucleoside-diphosphatase (dUDP), carbonate anhydrase, adenosine kinase, sarcosine oxidase, alphaketobutyrate dehydrogenase (mitochondrial), phosphatidylserine decarboxylase, glucose-6-phosphate isomerase, myo-inositol 1-phosphatase, ribonucleoside-diphosphate reductase, and dihydropteridine reductase;

(b) placing said mammalian cells in a selection medium, wherein the components of the selection medium exclude a component that complements the lack of expression of said protein;

(c) culturing said mammalian cells in said selection medium, wherein the culturing of said mammalian cells selects for at least one mammalian cell that expresses from said exogenous mammalian nucleic acid the protein lacking expression in said mammalian cell; and

(d) culturing said selected mammalian cell under conditions for expression of said product.

2. The method of claim 1 , wherein the component of the selection medium is selected from the group consisting of: arginine, cysteine, proline, tyrosine, myo-inositol, thymidine, ethanolamine, glucose, asparagine and glutamine.

3. The method of claim 1 , further comprising isolating the product expressed in the selected mammalian cell.

4. The method of claim 1 , wherein the selected mammalian cell comprises a gene disruption of the protein.

5. The method of claim 4 , wherein the gene disruption is a gene knockout.

6. The method of claim 1 , wherein the protein is selected from the group consisting of: argininosuccinate lyase, cystathionine G-lyase, cystathionine b-synthase, glycine N-methyltransferase, pyrroline-5-carboxylate synthetase, and phenylalanine 4-monooxygenase.

7. The method of claim 1 , wherein the component of the selection medium is selected from the group consisting of arginine, cysteine, proline, and tyrosine.

8. The method of claim 1 , wherein the exogenous mammalian nucleic acid is a mammalian expression vector.

9. The method of claim 1 , wherein the cell is a Chinese Hamster Ovary (CHO) cell.

10. A method of expressing a product in a mammalian cell, the method comprising:

(a) culturing mammalian cells comprising an exogenous mammalian nucleic acid that comprises (i) a nucleic acid encoding a protein not expressed in the mammalian cells and (ii) an expressible nucleic acid encoding a product, in a selection medium, wherein the components of the selection medium exclude a component that complements the lack of expression of the protein,

wherein the protein is selected from the group consisting of: argininosuccinate lyase, cystathionine G-lyase, cystathionine b-synthase, glycine N-methyltransferase, pyrroline-5-carboxylate synthetase, phenylalanine 4-monooxygenase, carbamoyl-phosphate synthase (ammonia), ornithine carbamoyltransferase (mitochondrial), ornithine transaminase (mitochondrial), methionine adenosyltransferase, adenosylhomocysteinase, propionyl-CoA carboxylase (mitochondrial), methylmalonyl-CoA epimerase (mitochondrial), methylmalonyl-CoA mutase, myo-Inositol-1-phosphate synthase, thymidylate synthase, nucleoside-diphosphatase (dUDP), carbonate anhydrase, adenosine kinase, sarcosine oxidase, alphaketobutyrate dehydrogenase (mitochondrial), phosphatidylserine decarboxylase, glucose-6-phosphate isomerase, myo-inositol 1-phosphatase, ribonucleoside-diphosphate reductase, and dihydropteridine reductase;

(b) selecting mammalian cells from step (a) that express the exogenous mammalian nucleic acid thereby allowing growth of the mammalian cells in the selection medium; and

(b) culturing the selected mammalian cells under conditions for expression of the product.

11. The method of claim 10 , wherein the protein is selected from the group consisting of: argininosuccinate lyase, cystathionine G-lyase, cystathionine b-synthase, glycine N-methyltransferase, pyrroline-5-carboxylate synthetase, and phenylalanine 4-monooxygenase.

12. The method of claim 10 , wherein the component of the selection medium is selected from arginine, cysteine, proline, tyrosine, myo-inositol, thymidine, ethanolamine, glucose, asparagine and glutamine.

13. The method of claim 12 , wherein the component of the selection medium is selected from the group consisting of arginine, cysteine, proline, and tyrosine.

14. The method of claim 10 , further comprising isolating the product expressed in the selected mammalian cell.

15. The method of claim 10 , wherein the exogenous mammalian nucleic acid is a mammalian expression vector.

16. The method of claim 10 , wherein the cell is a Chinese Hamster Ovary (CHO) cell.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 038541 FRAME 0563. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 30, 2017
From: FAMILI, IMANDOHKT; BLACK, RENATA USAITE
To: INTREXON CEU, INC.
Reel/Frame 044567/0212 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2017
From: SCHILLING, CHRISTOPHE H.
To: GENOMATICA, INC.
Reel/Frame 044228/0947 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 27, 2017
From: GENOMATICA, INC.
To: GT LIFE SCIENCES, INC.
Reel/Frame 044228/0955 →
MERGER AND CHANGE OF NAME Recorded Nov 27, 2017
From: GT LIFE SCIENCES, INC.; INTREXON CEU, INC.
To: INTREXON CEU, INC.
Reel/Frame 044228/0959 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2016
From: FAMILI, IMANDOHKT; BLACK, RENATA USAITE
To: INTREXON CORPORATION
Reel/Frame 038541/0563 →
Continuity (3)
Continuation 13218342 · Aug 25, 2011
Provisional Application 61377079 · Aug 25, 2010
Related Publication 20160160236A1 · Jun 9, 2016
Cited By (2)
US 12,668,774 US 12,686,847